Medline Inc. (MDLN) Stock Price & Analysis

Medline Inc. (MDLN) fell 5.19% to USD 34.69 as of September 9, 2026 at 13:14 UTC, according to Nexqual real-time market data.

MDLN last closed at USD 34.69; the session ranged USD 34.53–36.76 on volume of 7,214,712 shares. Market capitalization is —, with a 52-week range of USD 32.49–50.88 (NMS). Source: Nexqual, September 9, 2026 at 13:14 UTC.

Key Statistics (as of September 9, 2026 at 13:14 UTC)

Technical Analysis (MDLN)

Nexqual's technical model rates MDLN "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of September 9, 2026 at 13:14 UTC.

From Medline Inc.'s Latest SEC 10-K Filing (filed 2026-02-25)

Key Strengths & Strategy (as disclosed to the SEC)

• Supply Chain Solutions As of December 31, 2025, we offer approximately 145,000 med-surg products from over 1,300 third-party suppliers, including nearly all leading national brands, through our Supply Chain Solutions segment.
• The U.S. governmental and regulatory authorities that enforce such laws and rules, and that issue guidance on compliance with such laws and rules include, without limitation, the FDA, the Centers for Medicare & Medicaid Services ("CMS"), other divisions of the U.S.
• In addition, the FDA and other governmental and regulatory authorities, both in and outside the United States (including the FTC, the HHS Office of the Inspector General, the DOJ, and various state Attorneys General), monitor the promotion and advertising of our products.
• The NDA Approval Process For any new drug products regulated under the Federal Food, Drug, and Cosmetic Act such as our ReadyPrep CHG cloth, a sponsor must submit a New Drug Application ("NDA"), to the FDA for review and approval.

Partnerships

• Through continual improvement of internal processes, an awareness of market and candidate driven trends, and in partnership with vendors and other outside organizations, our talent acquisition programs focus on efficient hiring processes, market awareness, and building a diverse pipeline of candidates.
• Violations are subject to civil monetary penalties of up to $124,732 (which is adjusted annually for inflation) for each violation, plus up to three times the remuneration involved, and may result in criminal fines and imprisonment of up to ten years, and/or exclusion from Medicare, Medicaid, or other governmental programs.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 13:14 UTC. This page is informational and not investment advice.